Stada Looks To Take Slice Of Growing Probiotics Market With Launch Of Probielle In Germany
Stada Arzneimittel moves into the German probiotics market with four new products under its Probielle brand.
You may also be interested in...
Stada tells HBW Insight it remains on the lookout for deals despite only last month closing the acquisition of a basket of OTC brands from GSK. The German firm revealed its plans as it reported a double-digit rise in both sales and earnings at its Branded Products business for the opening six months of 2019.
Germany's Stada is on the look out for consumer health acquisitions globally that can help it reach its ambition to grow faster than the market in 2019. The firm's new private-equity owners are backing CEO Peter Goldschmidt's plan to take the Branded Products division to the next level.
Stada Arzneimittel is offering a new OTC option to the 1 in 3 Germans it claims suffer from fructose malabsorption with the launch of its new fructose intolerance food supplement, Fructosin.